Philippines - English - FDA (Food And Drug Administration)

n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - paracetamol , guaifenesin , phenylpropanolamine hydrochloride , dextromethorphan hydrobromide , chlorphenamine maleate - capsule - formulation: each capsule contains: paracetamol-325mg guaifenesin-50mg phenylpropanolamine hydrochloride-12.5mg dextromethorphan hydrobromide-10mg chlorphenamine maleate-1mg

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - phenylpropanolamine hydrochloride - syrup - 40 milligram(s)/millilitre - phenylpropanolamin

Ireland - English - HPRA (Health Products Regulatory Authority)

fatro s.p.a. - phenylpropanolamine hydrochloride - syrup - 40 milligram(s)/millilitre - phenylpropanolamin

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra ltd - phenylpropanolamine hydrochloride - oral solution/suspension - phenylpropanolamine hydrochloride ammonium-quaternary active 50.0 mg/ml - genitourinary system

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: water for injections - ephedrine hydrochloride injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 1 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 2 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 1 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

gladron chemicals sdn bhd - phenylpropanolamine hydrochloride -

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - terazosin hydrochloride anhydrous (unii: 8qop8z9955) (terazosin - unii:8l5014xet7) - terazosin 2 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.